| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Jun 09, 2026 |
Nuvalent Inc - Ordinary Shares - Class A
NUVL
|
BUY |
$124.00
Est. +1%
|
$122.88 | $123.62 |
Bullseye Hit (±1%)
|
$123.25
+0.3%
|
| Jun 03, 2026 |
Celcuity Inc
CELC
|
BUY |
$166.00
Est. +82%
|
$91.42 | $95.97 |
Pending
|
$88.55
-3.1%
|
| Feb 26, 2026 |
Revolution Medicines Inc
RVMD
|
BUY |
$144.00
Est. +39%
|
$103.24 | $166.50 |
Target Met
|
$153.87
+49.0%
|
| Oct 31, 2025 |
Immunocore Holdings plc - ADR
IMCR
|
BUY |
$60.00
Est. +86%
|
$32.19 | $40.71 |
Pending
|
$28.96
-10.0%
|
| May 28, 2025 |
ITeos Therapeutics Inc
ITOS
|
BUY |
$12.00
Est. +19%
|
$10.06 | $11.34 |
Miss
|
$10.15
+0.9%
|
| May 23, 2025 |
Bicara Therapeutics Inc. Common Stock
BCAX
|
SELL |
$8.00
Est. +14%
|
$9.27 | $8.51 (Low) |
Miss
|
$21.69
-134.0%
|
| May 14, 2025 |
ITeos Therapeutics Inc
ITOS
|
BUY |
$13.00
Est. +88%
|
$6.92 | $11.34 |
Miss
|
$10.15
+46.7%
|
| May 07, 2025 |
Arcus Biosciences Inc
RCUS
|
BUY |
$26.00
Est. +220%
|
$8.12 | $28.72 |
Target Met
|
$23.80
+193.1%
|
| Oct 08, 2024 |
Arcus Biosciences Inc
RCUS
|
BUY |
$29.00
Est. +60%
|
$18.08 | $18.98 |
Miss
|
$23.80
+31.6%
|
| Aug 13, 2024 |
ITeos Therapeutics Inc
ITOS
|
BUY |
$31.00
Est. +114%
|
$14.50 | $18.12 |
Miss
|
$10.15
-30.0%
|
| May 03, 2024 |
Kiniksa Pharmaceuticals International Plc. - Ordinary Shares - Class A
KNSA
|
BUY |
$34.00
Est. +75%
|
$19.38 | $28.15 |
Miss
|
$51.89
+167.8%
|